Kish SJ - Search Results

1

Nigral glutathione deficiency is not specific for idiopathic Parkinson's disease.

Fitzmaurice PS, Ang L, Guttman M, Rajput AH, Furukawa Y, Kish SJ. Fitzmaurice PS, et al. Among authors: kish sj. Mov Disord. 2003 Sep;18(9):969-76. doi: 10.1002/mds.10486. Mov Disord. 2003. PMID: 14502663

2

[¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders.

Payer DE, Guttman M, Kish SJ, Tong J, Strafella A, Zack M, Adams JR, Rusjan P, Houle S, Furukawa Y, Wilson AA, Boileau I. Payer DE, et al. Among authors: kish sj. Mov Disord. 2015 Feb;30(2):160-6. doi: 10.1002/mds.26135. Epub 2015 Jan 14. Mov Disord. 2015. PMID: 25641350

3

Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation.

Tong J, Ang LC, Williams B, Furukawa Y, Fitzmaurice P, Guttman M, Boileau I, Hornykiewicz O, Kish SJ. Tong J, et al. Among authors: kish sj. Neurobiol Dis. 2015 Oct;82:243-253. doi: 10.1016/j.nbd.2015.06.010. Epub 2015 Jun 21. Neurobiol Dis. 2015. PMID: 26102022 Free PMC article.

4

Do glutathione levels decline in aging human brain?

Tong J, Fitzmaurice PS, Moszczynska A, Mattina K, Ang LC, Boileau I, Furukawa Y, Sailasuta N, Kish SJ. Tong J, et al. Among authors: kish sj. Free Radic Biol Med. 2016 Apr;93:110-7. doi: 10.1016/j.freeradbiomed.2016.01.029. Epub 2016 Feb 1. Free Radic Biol Med. 2016. PMID: 26845616

5

Professor Oleh Hornykiewicz, MD (1926-2020): Remembering the Father of the Modern Treatment of Parkinson's Disease and the Man.

Rajput AH, Kish SJ. Rajput AH, et al. Among authors: kish sj. Mov Disord. 2020 Nov;35(11):1916-1921. doi: 10.1002/mds.28317. Epub 2020 Sep 28. Mov Disord. 2020. PMID: 32985723 Free PMC article. No abstract available.

6

Brain proteasomal function in sporadic Parkinson's disease and related disorders.

Furukawa Y, Vigouroux S, Wong H, Guttman M, Rajput AH, Ang L, Briand M, Kish SJ, Briand Y. Furukawa Y, et al. Among authors: kish sj. Ann Neurol. 2002 Jun;51(6):779-82. doi: 10.1002/ana.10207. Ann Neurol. 2002. PMID: 12112087

7

Brain dopamine-stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.

Tong J, Fitzmaurice PS, Ang LC, Furukawa Y, Guttman M, Kish SJ. Tong J, et al. Among authors: kish sj. Ann Neurol. 2004 Jan;55(1):125-9. doi: 10.1002/ana.10814. Ann Neurol. 2004. PMID: 14705122

8

Brain aconitase activity is not decreased in progressive supranuclear palsy.

Fitzmaurice PS, Bamsey CL, Ang L, Guttman M, Rajput AH, Furukawa Y, Kish SJ. Fitzmaurice PS, et al. Among authors: kish sj. Neurology. 2002 Jul 9;59(1):137-8. doi: 10.1212/wnl.59.1.137. Neurology. 2002. PMID: 12105325

9

Brain antioxidant systems in human methamphetamine users.

Mirecki A, Fitzmaurice P, Ang L, Kalasinsky KS, Peretti FJ, Aiken SS, Wickham DJ, Sherwin A, Nobrega JN, Forman HJ, Kish SJ. Mirecki A, et al. Among authors: kish sj. J Neurochem. 2004 Jun;89(6):1396-408. doi: 10.1111/j.1471-4159.2004.02434.x. J Neurochem. 2004. PMID: 15189342 Free article.

10

Levels of 4-hydroxynonenal and malondialdehyde are increased in brain of human chronic users of methamphetamine.

Fitzmaurice PS, Tong J, Yazdanpanah M, Liu PP, Kalasinsky KS, Kish SJ. Fitzmaurice PS, et al. Among authors: kish sj. J Pharmacol Exp Ther. 2006 Nov;319(2):703-9. doi: 10.1124/jpet.106.109173. Epub 2006 Jul 20. J Pharmacol Exp Ther. 2006. PMID: 16857724

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

299 results

Search Page

Filters